Sampson Danuta M, Dubis Adam M, Chen Fred K, Zawadzki Robert J, Sampson David D
Surrey Biophotonics, Centre for Vision, Speech and Signal Processing and School of Biosciences and Medicine, The University of Surrey, Guildford, GU2 7XH, UK.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Trust and UCL Institute of Ophthalmology, London, EC1V 2PD, UK.
Light Sci Appl. 2022 Mar 18;11(1):63. doi: 10.1038/s41377-022-00740-9.
The visualization and assessment of retinal microvasculature are important in the study, diagnosis, monitoring, and guidance of treatment of ocular and systemic diseases. With the introduction of optical coherence tomography angiography (OCTA), it has become possible to visualize the retinal microvasculature volumetrically and without a contrast agent. Many lab-based and commercial clinical instruments, imaging protocols and data analysis methods and metrics, have been applied, often inconsistently, resulting in a confusing picture that represents a major barrier to progress in applying OCTA to reduce the burden of disease. Open data and software sharing, and cross-comparison and pooling of data from different studies are rare. These inabilities have impeded building the large databases of annotated OCTA images of healthy and diseased retinas that are necessary to study and define characteristics of specific conditions. This paper addresses the steps needed to standardize OCTA imaging of the human retina to address these limitations. Through review of the OCTA literature, we identify issues and inconsistencies and propose minimum standards for imaging protocols, data analysis methods, metrics, reporting of findings, and clinical practice and, where this is not possible, we identify areas that require further investigation. We hope that this paper will encourage the unification of imaging protocols in OCTA, promote transparency in the process of data collection, analysis, and reporting, and facilitate increasing the impact of OCTA on retinal healthcare delivery and life science investigations.
视网膜微血管系统的可视化和评估在眼部及全身性疾病的研究、诊断、监测和治疗指导中具有重要意义。随着光学相干断层扫描血管造影(OCTA)技术的引入,无需使用造影剂即可对视网膜微血管系统进行容积可视化。许多基于实验室的和商业临床仪器、成像方案以及数据分析方法和指标,其应用往往不一致,导致情况混乱,这成为将OCTA应用于减轻疾病负担进程中的一个主要障碍。公开数据和软件共享,以及不同研究数据的交叉比较和汇总很少见。这些不足阻碍了建立健康和患病视网膜的带注释OCTA图像大型数据库,而这对于研究和定义特定病症的特征是必要的。本文阐述了规范人类视网膜OCTA成像所需的步骤,以解决这些局限性。通过对OCTA文献的综述,我们识别出问题和不一致之处,并提出成像方案、数据分析方法、指标、研究结果报告以及临床实践的最低标准,在无法做到的情况下,我们确定需要进一步研究的领域。我们希望本文将鼓励统一OCTA成像方案,促进数据收集、分析和报告过程的透明度,并有助于增强OCTA对视网膜医疗服务和生命科学研究的影响。